Regulatory Services

Comments

Post a Comment

Popular posts from this blog

6 Key Challenges in South Korea’s Pharma Regulations & Solutions

  South Korea is a rapidly growing pharmaceutical market with a well-established regulatory framework governed by the Ministry of Food and Drug Safety (MFDS). However, foreign pharmaceutical companies often face complex MFDS regulations when entering the market. Understanding these challenges and developing a strong regulatory submission strategy is essential for successful market entry. Here are six key regulatory challenges and strategies to overcome them: 1. Registration of Overseas Manufacturing Facilities  Foreign manufacturers must register their facilities with the MFDS before import declaration. This process involves strict compliance with MFDS regulations, detailed documentation, and adherence to Good Manufacturing Practices (GMP). How to Overcome It: Ensure early registration through the MFDS online platform. Maintain comprehensive documentation to meet MFDS regulatory submission requirements. Collaborate with local regulatory experts to streamline the submission pro...
Read more

Regulatory services in Japan

With a comprehensive Regulatory framework, Japan stands a competitive market for foreign medicinal and medical devices manufacturers while investing in the region. Not only the stringent regulations inclusive of language barriers, but also the expensive Regulatory procedural challenges demand a special attention from manufacturers, who are willing to enter the region. To get the market access, manufacturers must comply with Japan’s Pharmaceutical and Medical Device Act (PMD Act), which is regulated by the Pharmaceutical and Medical Devices Agency (PMDA). Freyr Provides  Regulatory services in Japan Leveraging our cutting-edge knowledge on the Japan’s Regulatory Affairs, Freyr, as a specialized Regulatory partner, can assist foreign manufacturers to streamline their device approval process cost-effectively and in a timely manner. Freyr’s Regulatory services in Japan span across: Medical devices Cosmetics Biotech
Read more

Regulatory services in Malaysia

Steadily growing economy along with the increasing demand for quality medicinal products and medical devices in Malaysia attracts foreign manufactures across the globe to invest in the region. To do so, manufacturers must get the market authorizations from the Ministry of Health. While the Drug Control Authority (DCA) oversees the pharmaceutical registrations in the region, the Malaysian Medical Devices Authority (MDA) regulates medical device registrations. Considering the rapid market expansion and radical regulatory transformations, Malaysian market access for foreign manufacturers would be anything but complicated and time consuming. Freyr Provides  Regulatory services in Malaysia With an updated Regulatory intelligence over the new Regulatory system of Malaysia, Freyr assists new market entrants to keep pace with the improved Regulatory requirements related to registrations, dossier compilation, submissions for necessary market authorizations. Freyr’s end-to-end Regulato...
Read more